PARSHALL B LYNNE Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$3M
Insider Sells Quantity
110
Insider Sells Sum
$50.79M

Insider Activity of PARSHALL B LYNNE

According to the SEC Form 4 filings, PARSHALL B LYNNE, being in a position of

  1. director at Ionis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 30000 shares for $1.59M,
    over all time since 2005-06-24, has bought 0 shares, and sold 1622862 shares for $47.83M.

Biography of PARSHALL B LYNNE

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $1,586,6653100

Comparison of Insiders on Amount of Buys and Sells

2025-11-07SaleArvinas, Inc.
ARVN
Chief Accounting Officer
230
0.0003%
$9.89$2,275+2.53%
2025-11-07PurchaseDine Brands Global, Inc.
DIN
director
4,082
0.0263%
$24.50$100,009+0.9%
2025-11-07SaleGreenlight Capital Re, Ltd.
GLRE
Grp Chief Underwriting Officer
9,942
0.0302%
$12.58$125,070-3.66%
2025-11-07SaleIMAX Corporation
IMAX
Chief Legal Officer Sr Exec VP
50,143
0.0994%
$34.67$1.74M-6.27%
2025-11-07PurchaseUnited Bankshares, Inc.
UBSI
director
138
–
$0$0
2025-11-06SaleAXT, Inc.
AXTI
CFO
22,675
0.0549%
$8.87$201,177-10.39%
2025-11-06SaleBKV Corporation
BKV
Chief Legal and Admin Officer
6,518
0.0082%
$25.00$162,950-5.64%
2025-11-06SaleBlackbaud, Inc.
BLKB
President and CEO
5,000
0.0093%
$57.68$288,409+11.02%
2025-11-06SaleBoston Scientific Corporation
BSX
director
12,891
0.0008%
$98.28$1.27M+2.48%
2025-11-06PurchaseCaterpillar Inc.
CAT
director
300
<0.0001%
$568.86$170,658+1.48%
2025-11-06PurchaseColony Bankcorp, Inc.
CBAN
CHIEF BANKING OFFICER
500
0.0029%
$16.25$8,125-1.6%
2025-11-06PurchaseCimpress plc
CMPR
EVP, Chief Financial Officer
4,000
0.0147%
$62.79$251,175+10.22%
2025-11-06SaleCONMED Corporation
CNMD
Executive Vice President & CFO
3,500
0.011%
$43.00$150,500+2.33%
2025-11-06SaleCenterPoint Energy, Inc.
CNP
director
6,200
0.001%
$38.83$240,746-1.52%
2025-11-06SaleCollegium Pharmaceutical, Inc.
COLL
EVP & Chief Financial Officer
30,000
0.1072%
$40.53$1.22M-11.17%
2025-11-06SaleDiebold Nixdorf, Incorporated
DBD
10 percent owner
40,522
0.1207%
$64.52$2.61M-8.33%
2025-11-06PurchaseDonegal Group Inc.
DGICA
10 percent owner
8,000
0.0228%
$19.13$153,034-1.98%
2025-11-06SaleEntegris, Inc.
ENTG
SVP and General Counsel
3,577
0.0023%
$88.41$316,243+3.57%
2025-11-06SaleEtsy, Inc.
ETSY
Chief Marketing Officer
3,095
0.0029%
$57.81$178,922+7.25%
2025-11-06PurchaseGeneral American Investors Company, Inc.
GAM
Chairman
168
–
$24.99$4,198+155.1%
Total: 828708
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.